← Back to Search

NIATx Coaching for HIV, Hepatitis C, and Opioid Use Disorder Management (BIRCH Trial)

N/A
Waitlist Available
Led By Frederick L Altice, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 6 months for 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will evaluate an intervention to introduce screening, evaluation and treatment of HIV/hep C/opioid use disorder in WV primary care clinics to improve health outcomes.

Who is the study for?
This trial is for Federally Qualified Health Centers and similar primary care clinics in West Virginia that provide adult care. It's not open to private or specialty clinics, or any clinic outside of West Virginia.
What is being tested?
The study tests a strategy called NIATx Coaching to integrate screening, evaluation, and treatment procedures for HIV, hepatitis C, and Opioid Use Disorder into primary care. Clinics will receive training and coaching to adopt these practices.
What are the potential side effects?
Since this trial focuses on integrating treatment strategies rather than testing new medications, it does not directly involve medication side effects. However, the process may uncover challenges in managing patients' conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every 6 months for 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and every 6 months for 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Integration of services
Number of patients initiated on antiretroviral medication (ART) for HIV
Number of patients initiated on medication for HCV
+6 more
Secondary study objectives
Number of patients on PrEP to prevent HIV
Number of patients retained on medication (ART) for HIV
Number of patients retained on medication for OUD for at least 6 months
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention - Nominal Group Technique, Training, CoachingExperimental Treatment1 Intervention
Each group of clinics will receive the same intervention in a step-wedge design, starting every 6-months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NIATx Coaching
2020
N/A
~270

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,922 Previous Clinical Trials
3,031,522 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,586 Previous Clinical Trials
3,328,510 Total Patients Enrolled
West Virginia UniversityOTHER
185 Previous Clinical Trials
64,753 Total Patients Enrolled

Media Library

Intervention - Nominal Group Technique, Training, Coaching Clinical Trial Eligibility Overview. Trial Name: NCT05668780 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: Intervention - Nominal Group Technique, Training, Coaching
Human Immunodeficiency Virus Infection Clinical Trial 2023: Intervention - Nominal Group Technique, Training, Coaching Highlights & Side Effects. Trial Name: NCT05668780 — N/A
Intervention - Nominal Group Technique, Training, Coaching 2023 Treatment Timeline for Medical Study. Trial Name: NCT05668780 — N/A
~9 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top